UnitedHealth Group Incorporated $UNH Stock Holdings Lessened by Spire Wealth Management

Spire Wealth Management trimmed its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 46.8% during the 2nd quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 16,594 shares of the healthcare conglomerate’s stock after selling 14,620 shares during the period. Spire Wealth Management’s holdings in UnitedHealth Group were worth $5,168,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also modified their holdings of the company. Brighton Jones LLC lifted its position in UnitedHealth Group by 176.2% during the 4th quarter. Brighton Jones LLC now owns 44,249 shares of the healthcare conglomerate’s stock worth $22,384,000 after acquiring an additional 28,231 shares during the last quarter. Revolve Wealth Partners LLC raised its position in UnitedHealth Group by 137.1% in the fourth quarter. Revolve Wealth Partners LLC now owns 4,019 shares of the healthcare conglomerate’s stock worth $2,033,000 after purchasing an additional 2,324 shares in the last quarter. Clear Creek Financial Management LLC raised its position in UnitedHealth Group by 9.7% in the first quarter. Clear Creek Financial Management LLC now owns 1,737 shares of the healthcare conglomerate’s stock worth $910,000 after purchasing an additional 153 shares in the last quarter. Arbor Trust Wealth Advisors LLC grew its stake in UnitedHealth Group by 6.0% during the first quarter. Arbor Trust Wealth Advisors LLC now owns 3,199 shares of the healthcare conglomerate’s stock worth $1,675,000 after buying an additional 182 shares during the last quarter. Finally, Keybank National Association OH grew its stake in shares of UnitedHealth Group by 5.0% during the first quarter. Keybank National Association OH now owns 207,524 shares of the healthcare conglomerate’s stock valued at $108,691,000 after purchasing an additional 9,907 shares during the last quarter. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

UNH has been the topic of several analyst reports. Sanford C. Bernstein increased their target price on shares of UnitedHealth Group from $379.00 to $433.00 and gave the stock an “outperform” rating in a report on Wednesday, October 8th. Truist Financial lifted their price objective on shares of UnitedHealth Group from $310.00 to $365.00 and gave the company a “buy” rating in a research report on Tuesday, September 9th. Royal Bank Of Canada lifted their target price on shares of UnitedHealth Group from $286.00 to $408.00 and gave the stock an “outperform” rating in a report on Wednesday. KeyCorp lifted their price objective on shares of UnitedHealth Group from $350.00 to $400.00 and gave the stock an “overweight” rating in a research note on Wednesday, October 8th. Finally, Baird R W cut shares of UnitedHealth Group from a “hold” rating to a “strong sell” rating in a research report on Thursday, July 31st. Eighteen equities research analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and three have assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, UnitedHealth Group currently has an average rating of “Moderate Buy” and a consensus target price of $395.64.

UnitedHealth Group Stock Down 3.2%

UnitedHealth Group stock opened at $356.05 on Thursday. The company has a quick ratio of 0.85, a current ratio of 0.82 and a debt-to-equity ratio of 0.71. The firm’s fifty day moving average is $342.00 and its 200 day moving average is $331.00. UnitedHealth Group Incorporated has a 12-month low of $234.60 and a 12-month high of $630.73. The company has a market capitalization of $322.47 billion, a PE ratio of 18.58, a PEG ratio of 2.37 and a beta of 0.47.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Tuesday, October 28th. The healthcare conglomerate reported $2.92 EPS for the quarter, beating the consensus estimate of $2.87 by $0.05. The company had revenue of $113.16 billion during the quarter, compared to the consensus estimate of $113.19 billion. UnitedHealth Group had a net margin of 4.04% and a return on equity of 19.23%. The firm’s revenue for the quarter was up 12.2% on a year-over-year basis. During the same quarter in the prior year, the company posted $7.15 earnings per share. As a group, sell-side analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, September 23rd. Stockholders of record on Monday, September 15th were given a $2.21 dividend. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.5%. The ex-dividend date was Monday, September 15th. UnitedHealth Group’s dividend payout ratio (DPR) is 38.30%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.